Work

A pilot study of interferon-alpha-2b dose reduction in melanoma: High dose interferon is not necessary for optimal activation of immune signal transduction.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e20035

Authors: Kala M. Levine, Sara E. Martin Del Campo, Taylor Brooks, Elizabeth Streaker, Leslee Sprague, Volodymr Karpa, Joseph Markowitz, Anissa Bingman, Susan Michelle Geyer, Thomas Olencki, Kari Lynn Kendra, William Edgar Carson

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, University of Cincinnati, ProMedica Toledo Hospital, The Ohio State University

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598961336

Cites:

Cited by:

Related to: 10